Xeris Biopharma Holdings Inc (XERS)
3.09
+0.05
(+1.64%)
USD |
NASDAQ |
Nov 22, 16:00
3.085
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Cash from Financing (Quarterly): -0.083M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.083M |
| June 30, 2024 | 0.659M |
| March 31, 2024 | 35.19M |
| December 31, 2023 | -1.234M |
| September 30, 2023 | -0.072M |
| June 30, 2023 | 0.556M |
| March 31, 2023 | -0.863M |
| December 31, 2022 | 49.16M |
| September 30, 2022 | -0.187M |
| June 30, 2022 | 0.31M |
| March 31, 2022 | 78.19M |
| December 31, 2021 | 0.125M |
| September 30, 2021 | 0.001M |
| June 30, 2021 | 0.46M |
| March 31, 2021 | 26.66M |
| December 31, 2020 | 3.326M |
| Date | Value |
|---|---|
| September 30, 2020 | 13.06M |
| June 30, 2020 | 69.61M |
| March 31, 2020 | 40.07M |
| December 31, 2019 | 1.97M |
| September 30, 2019 | 22.57M |
| June 30, 2019 | -0.157M |
| March 31, 2019 | 56.15M |
| December 31, 2018 | 0.029M |
| September 30, 2018 | 13.18M |
| June 30, 2018 | 90.80M |
| March 31, 2018 | 24.20M |
| December 31, 2017 | 5.467M |
| September 30, 2017 | 0.019M |
| June 30, 2017 | 30.02M |
| March 31, 2017 | -0.368M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.234M
Minimum
Dec 2023
78.19M
Maximum
Mar 2022
15.85M
Average
0.6075M
Median
Cash from Financing (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 64.76M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | -0.127M |
| iBio Inc | -0.162M |
| Theriva Biologics Inc | 3.716M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.305M |
| Cash from Investing (Quarterly) | 9.914M |
| Free Cash Flow | -32.26M |
| Free Cash Flow Per Share (Quarterly) | -0.0563 |
| Free Cash Flow to Equity (Quarterly) | -9.195M |
| Free Cash Flow to Firm (Quarterly) | -2.952M |
| Free Cash Flow Yield | -7.25% |